1-deoxynojirimycin has been researched along with Hepatitis B, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Block, TM; Blumberg, BS; Dwek, RA; Ebling, M; Jacob, GS; Korba, B; Lansky, DM; Lu, X; Mehta, AS; Tennant, B | 1 |
1 trial(s) available for 1-deoxynojirimycin and Hepatitis B, Chronic
Article | Year |
---|---|
Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking.
Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Biological Transport; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Glucosides; Glycoside Hydrolase Inhibitors; Glycosylation; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Mannosides; Marmota; Oligosaccharides; Protein Folding; Rodent Diseases; Virus Replication | 1998 |